Review form: Reviewer 2 (Teun Dekker)
Is the manuscript scientifically sound in its present form? Yes
Are the interpretations and conclusions justified by the results? Yes

Is the language acceptable? Yes
Is it clear how to access all supporting data? Yes
Do you have any ethical concerns with this paper? No
Have you any concerns about statistical analyses in this paper? No
Recommendation? Accept as is
Comments to the Author(s)
The authors have in my opinion responded well to the critique of the reviewers, save some little misunderstanding. I attach a file with some responses and minor points. Nice if the authors can accommodate these (Appendix A).
Best, Teun Dekker
Decision letter (RSOS-182050.R0) 31-Jan-2019 Dear Dr Groot On behalf of the Editors, I am pleased to inform you that your Manuscript RSOS-182050 entitled "Within-population variability in a moth sex pheromone blend, part 2: Selection towards fixation" has been accepted for publication in Royal Society Open Science subject to minor revision in accordance with the referee suggestions. Please find the referees' comments at the end of this email.
The reviewers and handling editors have recommended publication, but also suggest some minor revisions to your manuscript. Therefore, I invite you to respond to the comments and revise your manuscript.
• Ethics statement If your study uses humans or animals please include details of the ethical approval received, including the name of the committee that granted approval. For human studies please also detail whether informed consent was obtained. For field studies on animals please include details of all permissions, licences and/or approvals granted to carry out the fieldwork.
• Data accessibility It is a condition of publication that all supporting data are made available either as supplementary information or preferably in a suitable permanent repository. The data accessibility section should state where the article's supporting data can be accessed. This section should also include details, where possible of where to access other relevant research materials such as statistical tools, protocols, software etc can be accessed. If the data has been deposited in an external repository this section should list the database, accession number and link to the DOI for all data from the article that has been made publicly available. Data sets that have been deposited in an external repository and have a DOI should also be appropriately cited in the manuscript and included in the reference list.
If you wish to submit your supporting data or code to Dryad (http://datadryad.org/), or modify your current submission to dryad, please use the following link: http://datadryad.org/submit?journalID=RSOS&manu=RSOS-182050
• Competing interests Please declare any financial or non-financial competing interests, or state that you have no competing interests.
• Authors' contributions All submissions, other than those with a single author, must include an Authors' Contributions section which individually lists the specific contribution of each author. The list of Authors should meet all of the following criteria; 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published.
All contributors who do not meet all of these criteria should be included in the acknowledgements.
We suggest the following format: AB carried out the molecular lab work, participated in data analysis, carried out sequence alignments, participated in the design of the study and drafted the manuscript; CD carried out the statistical analyses; EF collected field data; GH conceived of the study, designed the study, coordinated the study and helped draft the manuscript. All authors gave final approval for publication.
• Acknowledgements Please acknowledge anyone who contributed to the study but did not meet the authorship criteria.
• Funding statement Please list the source of funding for each author.
Please ensure you have prepared your revision in accordance with the guidance at https://royalsociety.org/journals/authors/author-guidelines/ --please note that we cannot publish your manuscript without the end statements. We have included a screenshot example of the end statements for reference. If you feel that a given heading is not relevant to your paper, please nevertheless include the heading and explicitly state that it is not relevant to your work.
Because the schedule for publication is very tight, it is a condition of publication that you submit the revised version of your manuscript before 09-Feb-2019. Please note that the revision deadline will expire at 00.00am on this date. If you do not think you will be able to meet this date please let me know immediately.
To revise your manuscript, log into https://mc.manuscriptcentral.com/rsos and enter your Author Centre, where you will find your manuscript title listed under "Manuscripts with Decisions". Under "Actions," click on "Create a Revision." You will be unable to make your revisions on the originally submitted version of the manuscript. Instead, revise your manuscript and upload a new version through your Author Centre.
When submitting your revised manuscript, you will be able to respond to the comments made by the referees and upload a file "Response to Referees" in "Section 6 -File Upload". You can use this to document any changes you make to the original manuscript. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response to the referees. We strongly recommend uploading two versions of your revised manuscript: 1) Identifying all the changes that have been made (for instance, in coloured highlight, in bold text, or tracked changes); 2) A 'clean' version of the new manuscript that incorporates the changes made, but does not highlight them.
When uploading your revised files please make sure that you have: 1) A text file of the manuscript (tex, txt, rtf, docx or doc), references, tables (including captions) and figure captions. Do not upload a PDF as your "Main Document"; 2) A separate electronic file of each figure (EPS or print-quality PDF preferred (either format should be produced directly from original creation package), or original software format); 3) Included a 100 word media summary of your paper when requested at submission. Please ensure you have entered correct contact details (email, institution and telephone) in your user account; 4) Included the raw data to support the claims made in your paper. You can either include your data as electronic supplementary material or upload to a repository and include the relevant doi within your manuscript. Make sure it is clear in your data accessibility statement how the data can be accessed; 5) All supplementary materials accompanying an accepted article will be treated as in their final form. Note that the Royal Society will neither edit nor typeset supplementary material and it will be hosted as provided. Please ensure that the supplementary material includes the paper details where possible (authors, article title, journal name).
Supplementary files will be published alongside the paper on the journal website and posted on the online figshare repository (https://rs.figshare.com/). The heading and legend provided for each supplementary file during the submission process will be used to create the figshare page, so please ensure these are accurate and informative so that your files can be found in searches. Files on figshare will be made available approximately one week before the accompanying article so that the supplementary material can be attributed a unique DOI.
Please note that Royal Society Open Science charge article processing charges for all new submissions that are accepted for publication. Charges will also apply to papers transferred to Royal Society Open Science from other Royal Society Publishing journals, as well as papers submitted as part of our collaboration with the Royal Society of Chemistry (http://rsos.royalsocietypublishing.org/chemistry).
If your manuscript is newly submitted and subsequently accepted for publication, you will be asked to pay the article processing charge, unless you request a waiver and this is approved by Royal Society Publishing. The reviewers are largely satisfied with your changes, but recommend some additional modifications to hone an otherwise promising piece of work -good luck and we look forward to receiving the revision.
Reviewer comments to Author: Reviewer: 1 Comments to the Author(s) I begin by reiterating my previous assessment that this is a very well-constructed manuscript that describes an excellent series of experiments. The core result is the discovery of a stop codon mutation in a desaturase gene that has a profound effect on female pheromone blend but no detectable effect on male response or other fitness components. This will certainly be of interest in the field of pheromone communication and the wider field of signal-response evolution. My principal concern with the version that I saw previously was a tendency to over-state the significance of the results. This arose largely through implying extension of the observations on this laboratory mutation to variation in natural populations. With some reluctance, the authors have adjusted the MS appropriately, in most places, as well as responding to my other minor comments and those of the second reviewer. I have a few remaining issues. They are all small wording changes, in a sense, but I think they are significant in terms of getting the message right. Final sentence of abstract -"… a single point mutation that underlies the phenotypic variation…". This is still inclined to give the wrong impression because 'the phenotypic variation' can easily be read as the variation present in nature. " … a single point mutation that alters the pheromone signal of a moth" would be preferable. 69 -I suggest replacing 'within-population variation' with 'difference between lines'. Then on line 73, make clear that this is 99% of the variance in the QTL cross, not in the source population and on line 75 replace 'contributes to the within-population female pheromone variation' with 'can contribute to female pheromone variation'. 258-260 -is 'X-square' here the same as 'Chi-square'? If so, the numbers look to be incorrect. If not, please explain the test. I don't agree that p=0.066 is 'marginal significant' (now line 318), even if the authors 'prefer' this wording (see response). The authors actually describe it as 'just missed significance' on line 225. If the cut-off is p=0.05, this is simply not significant. 331-2 -"These results confirm that in Heliothis virescens, independent and unlinked genes govern the variation in the female pheromone signal and the male pheromone response." I disagree. The results reveal a single mutation in a single gene that influences pheromone blend but not male response. This may tend to support a general picture of independent genetic determination but it does not 'confirm' it. 339-348 -this is a useful addition. I think that the genetic independence of pheromone blend and male response in Ostrinia should also be mentioned at this point. It would also be good to mention here the evidence in Heliconius (Lepidoptera) for pleiotropic effects on preference of major genes influencing visual signals. [cited as ref. 24] In response to Rev. 2, the authors say: "Loss of a functional delta-11 desaturase activity in the female pheromone gland of H. gelotopoeon is the only possible explanation of this phenomenon. Therefore it is appropriate to retain the reference to saltational evolution at this point of the Discussion." The implication is that loss of function must be saltational (now line 370). I don't agree. The end result of loss of function can be reached in a series of small steps. Decision letter (RSOS-182050.R1) 18-Feb-2019 Dear Dr Groot, I am pleased to inform you that your manuscript entitled "Within-population variability in a moth sex pheromone blend, part 2: Selection towards fixation" is now accepted for publication in Royal Society Open Science.
You can expect to receive a proof of your article in the near future. Please contact the editorial office (openscience_proofs@royalsociety.org and openscience@royalsociety.org) to let us know if you are likely to be away from e-mail contact. Due to rapid publication and an extremely tight schedule, if comments are not received, your paper may experience a delay in publication.
Royal Society Open Science operates under a continuous publication model (http://bit.ly/cpFAQ). Your article will be published straight into the next open issue and this will be the final version of the paper. As such, it can be cited immediately by other researchers. As the issue version of your paper will be the only version to be published I would advise you to check your proofs thoroughly as changes cannot be made once the paper is published. I suggest to change pheromone compound to pheromone GLAND compound/component. The difference between component/compound is not so generally understood. I would strongly advise to revise so no-one gets confused.
-line 27 : the dynamic mechanisms. I am not sure if one should call the mechanisms dynamic or rather diverse, the first implying that the mechanisms (eg selected genes that induce change) are themselves dynamic .. well you get the idea Answer: We don't understand the reviewer's point here, but we have removed the word "dynamic".
to clarify: dynamic mechanisms imply that the mechanisms themselves are dynamic instead of (what is meant) that mechanisms cause pheromone communication to be dynamic (as implied by evolution).
-line 298: does amount of precursor being generated (in this case 16Ald) depend on the activity of the enzyme that converts it to the pheromone (in this case z11-16Ald)? This is the case in many microbes. I mention this as inthe low lines increasing the amount of Z11-16Ald (eg higher enzymatic conversion) could simply lead to more 16Ald be produced (maybe with pleiotropic effects on Z9-14Ald, see also fig 1a and comments below) and thus not change the ratio. In that light it could be good if the authors not only present relative amounts, but also absolute quantities (if the the above would be true one would expect more pheromone compounds and precursors in the low lines) Answer: We do not understand the reviewer's point, as he writes that an increasing amount of Z11-16:Ald can lead to more 16:Ald, which is opposite to our observations. Moreover, we have not assayed enzyme activity directly. It is the ratio between 16:Ald and Z11-16:Ald that is changed, as is written throughout the manuscript (i.e the ratio being < 1 or > 1), meaning that more 16:Ald is directly related to less Z11-16:Ald. To explain: In biological systems, depleting a substrate by higher enzymatic activity can lead to an increased production of the substrate. In this case, when selecting for lower 16:Ald, the slection lines may have favored increased enzymatic activity in the gland. This may have caused more 16:ald being produced (nd converted into pheromone components). In effect there is no change in ratio. However, there may be a change in absolute amount of pheromone components being produced. However, the authors did now mentioned that the absolute quantity in the low lines was lower than the high lines, which shows that the above is not the case. Please insert a line in the results on the absolute quantity
